Effect of WIM Hof Breathing in chronic kidney disease patients
Not Applicable
- Conditions
- Health Condition 1: N189- Chronic kidney disease, unspecified
- Registration Number
- CTRI/2023/04/051907
- Lead Sponsor
- MGM Institute Of Physiotherapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients diagnosed with chronic kidney disease.
2. Patients with both genders between 35- 65 yrs of age.
3. Patients who are willing to participate in the study.
Exclusion Criteria
1. Patients with respiratory problem.
2. Epilepsy
3. Coronary heart disease
4. A history of heart failure or stroke.
5. Pregnant or lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pittsburgh Sleep Quality Index (PSQI)- for assessing sleep qualityTimepoint: At baseline and at 1 week
- Secondary Outcome Measures
Name Time Method Sphygmomanometer- for assessing blood pressureTimepoint: At baseline and at 1 week
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie WIM Hof Breathing's impact on blood pressure in chronic kidney disease patients?
How does WIM Hof Breathing compare to standard-of-care treatments for managing hypertension and sleep disturbances in N189 patients?
Are there specific biomarkers that correlate with improved sleep quality and blood pressure outcomes in chronic kidney disease patients practicing WIM Hof Breathing?
What are the potential adverse events associated with WIM Hof Breathing in patients with unspecified chronic kidney disease, and how can they be managed?
What combination therapies or alternative approaches are being explored alongside WIM Hof Breathing for chronic kidney disease management?